Effect of levosimendan on ventricular remodelling in patients with left ventricular systolic dysfunction: a meta‐analysis

Abstract Heart failure is the final stage of several cardiovascular diseases, and the key to effectively treating heart failure is to reverse or delay ventricular remodelling. Levosimendan is a novel inotropic and vasodilator agent used in heart failure, whereas the impact of levosimendan on ventric...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Xia Wang, Xiu‐Zhi Zhao, Xi‐Wen Wang, Lu‐Ying Cao, Bin Lu, Zhi‐Hao Wang, Wei Zhang, Yun Ti, Ming Zhong
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Oxford University Press 2024-06-01
coleção:	ESC Heart Failure
Assuntos:	Levosimendan Left ventricular systolic dysfunction Ventricular remodelling Safety Meta‐analysis
Acesso em linha:	https://doi.org/10.1002/ehf2.14714
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!